Anavatos Bio
Anavatos Bio is an early-stage biotechnology start-up based in Seattle, Washington, dedicated to revolutionizing biologics manufacturing. The company is driven by a team of experienced scientists, engineers, and entrepreneurs passionate about increasing access to protein therapeutics. Their mission is to enable faster, more efficient, and cost-effective production of biologics at smaller scales, supporting early-phase research and advancing a new medical paradigm that delivers greater value to patients.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Integrated platform for small-scale biologics production
A system-oriented platform intended to enable representative, low-volume production of protein therapeutics with reduced cost and faster turnaround compared with conventional large-volume manufacturing.
Integrated platform for small-scale biologics production
A system-oriented platform intended to enable representative, low-volume production of protein therapeutics with reduced cost and faster turnaround compared with conventional large-volume manufacturing.
Expertise Areas
- Small-scale biologics manufacturing
- Early-phase (preclinical and Phase I) biologics production
- Process development and optimization for low-volume production
- Integrated end-to-end manufacturing systems
Key Technologies
- Small-batch/low-volume biomanufacturing
- End-to-end manufacturing platforms
- Process automation and workflow optimization
- Early-phase manufacturing workflows
News & Updates
Industry publication discussing the need for automation and lower costs in bioprocess contract manufacturing, supporting Anavatos Bio's mission.
Article on the adoption of single-use technologies in biomanufacturing, aligning with Anavatos Bio's focus on efficiency and innovation.
Explores the challenges and opportunities in continuous manufacturing, relevant to Anavatos Bio's technological approach.
Discusses the trend of outsourcing to contract development and manufacturing organizations, highlighting the need for shorter turnaround times.
A government report on advanced manufacturing strategies, supporting the need for innovation in the field.
Article on modular and single-use technologies driving the future of biomanufacturing, supporting Anavatos Bio's mission for waste reduction and efficiency.
Industry publication discussing the need for automation and lower costs in bioprocess contract manufacturing, supporting Anavatos Bio's mission.
Article on the adoption of single-use technologies in biomanufacturing, aligning with Anavatos Bio's focus on efficiency and innovation.
Explores the challenges and opportunities in continuous manufacturing, relevant to Anavatos Bio's technological approach.
Discusses the trend of outsourcing to contract development and manufacturing organizations, highlighting the need for shorter turnaround times.
A government report on advanced manufacturing strategies, supporting the need for innovation in the field.
Article on modular and single-use technologies driving the future of biomanufacturing, supporting Anavatos Bio's mission for waste reduction and efficiency.